FDA Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests

📢 The U.S. FDA launched a new program - the Commissioner’s National Priority Voucher (CNPV) - to shorten review timelines from 10-12 months to 1-2 months following a sponsor’s final drug application submission.

⭐ The vouchers will be given only to the companies that are aligned with U.S. national priorities.

⭐ Attached is the slide deck with additional details.

📧 For further details, please write to us at support@oncofocus.com.

🌐 References:

1) https://www.fda.gov/news-events/press-announcements/fda-issue-new-commissioners-national-priority-vouchers-companies-supporting-us-national-interests

2) https://www.fda.gov/news-events/press-announcements/faqs-commissioners-national-priority-voucher-program